Head and Neck Cancer Therapy
Investigators at Turku University have published new data on head and neck cancer therapy
Published in Hospital Law Weekly, January 3rd, 2008
A report, 'Concomitant chemoirradiation with vinorelbine and gefitinib induces additive effect in head and neck squamous cell carcinoma cell lines in vitro,' is newly published data in Radiotherapy and Oncology. "The study was performed to measure the radiosensitizing effect of vinorelbine together with gefitinib in head and neck squamous cell carcinoma (HNSCC) cell lines in vitro. Three recently established HNSCC cell lines, originating from larynx and oral cavity tumors, were tested in this study," researchers in Finland report.
"Vinorelbine concentration of 0.5 nM was used, corresponding to the IC(70) value of cell lines. Gefitinib concentrations of 0.10-0.35...
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Hospital Law Weekly
Source: Hospital Law Weekly (2008-01-03)
More Articles from Hospital Law Weekly
- Adenoma
Studies from Moorfields Eye Hospital provide new data on adenoma - Anthony Ostlund & Baer
Anthony Ostlund & Baer Obtains $130 Million Jury Verdict for Minnesota Dental Group - Cancer Therapy
Research from University of Sheffield in the area of cancer therapy described - Critical Care Medicine
Data on critical care medicine discussed by researchers at University of Witten - Dialog Medical
Department of Veterans Affairs Renews Contract with Dialog Medical - Economic Policy
Study findings on economic policy are outlined in reports from University of Pennsylvania - More from this issue of Hospital Law Weekly
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
